Zinplava Injection, Solution
Product Images NDC 0006-3025

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Zinplava (NDC 0006-3025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1,000 mg/40 mL Vial Carton)

Zinplava is an injection that contains 1,000mg of bezlotoxumab in 40mL of solution. Each mL of solution contains 25mg bezlotoxumab, ditic acid monohydrate, dithylenetriamine-pentaacetic acid, polysorbate 80, sodium chloride, sodium ditate divydrate, and Water for Injection, USP. It may contain sodium hydroxide to adjust pH to 6.0. Zinplava should be store refrigerated at 2°C-8°C (36°F-46°F) in the original carton to protect from light. It is for intravenous infusion only and requires dilution prior to administration. Each vial is a single-dose vial and unused portions should be discarded. See package insert for details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.